Status:
RECRUITING
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Lead Sponsor:
Carevive Systems, Inc.
Conditions:
Breast Cancer
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote sym...
Eligibility Criteria
Inclusion
- All participants must be 18 years of age or older.
- Subjects may be any stage and anywhere in the treatment continuum.
- Subject participants must have a diagnosis of a breast, lung, AML, ovarian cancer or multiple myeloma.
- Subjects must be able to complete on-line surveys using a cell phone, tablet, or computer.
- All participants must be able to understand English.
Exclusion
- Any patient who cannot understand written or spoken English.
- Any patient without the ability to complete on-line surveys using a cell phone, tablet, or computer.
- Any patient on a treatment clinical trial.
- Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D).
Key Trial Info
Start Date :
July 19 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT05974150
Start Date
July 19 2023
End Date
December 31 2025
Last Update
February 12 2025
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale Cancer Center
New Haven, Connecticut, United States, 06511
2
Northshore University Health System
Evanston, Illinois, United States, 31024
3
Univeristy of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27599
4
Duke
Durham, North Carolina, United States, 27707